RELATIONSHIP BETWEEN SOME IMMUNOLOGICAL FACTORS AND TYPE 2 DIABETES MELLITUS IN IRAQI PATIENTS
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i6.25881Keywords:
IL-6, IL-8, IGF, Diabetes mellitus, Iraqi PatientsAbstract
Objective: To determine whether elevated levels of the inflammatory markers interleukin 6 (IL-6), interleukin 8 (IL-8) and insulin – like growth factor-1 are associated with development of type 2 DM in Iraqi sample.
Methods: A total number of 150 samples in this study, including 75 diabetes mellitus patients and 75 healthy people (control) This study was conducted from August 2016 to February 2017. All samples were collected from Anbar city, Iraq. Serum concentrations of IL-6, IL-8 and IGF. were determined using a commercially available enzyme-linked immune sorbent assay (ELISA).
Results: The results of the present study showed that there was a difference in the mean values of IL-6, IL-8 and IFG between the group of patients with type 2 diabetes and the control group The results showed a negative correlation between IL-6 and IL-8, while the correlation between IL-6 and IGF and between IL -8 and IGF was showed positive correlation
Conclusion: Elevated levels of IL-6 and IL-8 predict the development of type 2 DM. These data support a possible role for inflammation in diabetogenesis. Type 2 diabetes as well as pre-diabetic states, including impaired fasting glucose and impaired glucose tolerance, are associated cross-sectionally with altered circulating levels of IGF-I . decline in the levels of IGF-I dependent on duration of diabetes in non insuline dependent diabetic patients.
Downloads
References
Malenica M, Šilar M, Dujić T, Bego T, Semiz S, Škrbo S, et al. Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus. Med Glas (Zenica) 2017;14:169-75.
Al-Biati HA, Sahib AS, Ismail SH. Effects of metformin and glibenclaimide combination in Iraqi obese patients with metabolic syndrome. Int J Pharm Pharm Sci 2014;6:501-3.
Razavi GS, Allen T. Emerging role of interleukins in cancer treatment. Immunome Res 2015;S2:1745-7580.
Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 2012;8:1254-66.
Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006;82:S3.
Reddy NM, Reddy NR, Jamil K. Spicy anti-cancer spices: A review. Int J Pharm Pharm Sci 2015;7:1-6.
Swapnil N. Rajpathak, Gunter MJ, Wylie-Rosett J, Ho YFG, Robert C. Kaplan, Muzumdar R et al. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 2009;25:3–12.
Sesti G, Vatrano M, Sciacqua A, Succurro E, Cardellini M, Lauro R. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005;28:132-7.
Simpson RJ, Hammacher A, Smith DK. Interleukin-6: Structure-function relationships. Protein Sci 1997;6:6929-955.
Biffl WL, Moore EE, Moore FA. Interleukin-6 in the injured patient marker of injury or mediator of inflammation? Ann Surg 1996;224:647 64.
Benakanakere MR, Finoti LS, Tanaka U, Grant GR. Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/ Cas9 mediated genome editing. Sci Rep 2016;6:31180.
Tavangar A, Khozeimeh F, Ghoreishian F, Boroujeni MA. Serum level of Interleukin-8 in subjects with diabetes, diabetes plus oral lichen planus, and oral lichen planus: A biochemical study. Dent Res J (Isfahan) 2016;13:413-8.
Shih YL, Ho KT, Tsao CH, Chang YH, Shiau MY, Huang CN, et al. Role of cyotkines in metabolism and type 2 diabetes mellitus. Int J Biomed Lab Sci 2013;2:1-6.
Gupta S, Maratha A, Siednienko J, Natarajan A, Gajanayake T, Hoashi S, Miggin S. Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications. Sci Rep 2017;7:7633.
Friedrich N, Spielhagen C, Thuesen B, Wallaschofksi H, Jørgensen T, Linneberg A, et al. The association between IGF-I and insulin resistance. Diabetes Care 2012;35:768-73.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor b, and TNF-a: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 2016;138:984-1010.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
